Visualitza per autor "Kim, Sung‑Bae"
Ara mostrant els elements 1-3 d 3
-
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
Dent, Rebecca; O’Shaughnessy, Joyce; Kim, Sung‑Bae; Isakoff, S. J.; Barrios, Carlos; Antunes de Melo Oliveira, Ana Mafalda; Turner, Nicholas (Springer, 2022-02) -
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
Moy, Beverly; Antunes de Melo Oliveira, Ana Mafalda; Gradishar, William; Kim, Sung‑Bae; Brufsky, Adam; Saura Manich, Cristina (Oxford University Press, 2021-07) -
Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)
Modi, Shanu; Krop, Ian; Park, Yeon Hee; Kim, Sung‑Bae; Tamura, K.; Saura Manich, Cristina (Elsevier, 2024-03)